title: [Antituberculous chemotherapy: a constraining adverse effect of pyrazinamide].
authors.forename: P
authors.initials: P
authors.lastname: Mignot
authors.forename: R
authors.initials: R
authors.lastname: Dumas
authors.forename: J
authors.initials: J
authors.lastname: Lavarenne
authors.forename: C
authors.initials: C
authors.lastname: Molina
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D006261:Headache / Q000139:chemically induced*; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced*; D008297:Male; D010292:Paresthesia / Q000139:chemically induced*; D011718:Pyrazinamide / Q000009:adverse effects*; D014396:Tuberculosis, Pleural / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
chemical_list: D011718:Pyrazinamide
vernacular_title: Chimiothérapie antituberculeuse: un effet secondaire contraignant du pyrazinamide.